Journal article 164 views
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study
Arne Ring 
,
Tom Morris,
Marcin Wozniak,
Nikol Sullo ,
William Dott,
Veerle Verheyden,
Tracy Kumar,
Nigel Brunskill,
Rakesh Vaja,
Gavin J. Murphy
,
Tom Morris,
Marcin Wozniak,
Nikol Sullo ,
William Dott,
Veerle Verheyden,
Tracy Kumar,
Nigel Brunskill,
Rakesh Vaja,
Gavin J. Murphy
British Journal of Clinical Pharmacology, Volume: 83, Issue: 4, Pages: 709 - 720
Swansea University Author:
Nikol Sullo
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1111/bcp.13162
Abstract
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study
| Published in: | British Journal of Clinical Pharmacology |
|---|---|
| ISSN: | 0306-5251 1365-2125 |
| Published: |
Wiley
2017
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa70513 |
| first_indexed |
2025-09-25T16:01:59Z |
|---|---|
| last_indexed |
2025-10-10T21:32:07Z |
| id |
cronfa70513 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2025-10-09T16:40:54.2569667</datestamp><bib-version>v2</bib-version><id>70513</id><entry>2025-09-25</entry><title>A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study</title><swanseaauthors><author><sid>a2c2be54c418e779fd6a010486e1c730</sid><ORCID>0000-0002-9885-5474</ORCID><firstname>Nikol</firstname><surname>Sullo</surname><name>Nikol Sullo</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2025-09-25</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>British Journal of Clinical Pharmacology</journal><volume>83</volume><journalNumber>4</journalNumber><paginationStart>709</paginationStart><paginationEnd>720</paginationEnd><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0306-5251</issnPrint><issnElectronic>1365-2125</issnElectronic><keywords>cardiac surgery; clinical pharmacology; dose proportionality; nitrite oxide; pharmacokinetics; sildenafil</keywords><publishedDay>1</publishedDay><publishedMonth>4</publishedMonth><publishedYear>2017</publishedYear><publishedDate>2017-04-01</publishedDate><doi>10.1111/bcp.13162</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>British Heart Foundation. Grant Numbers: CH/12/1/29419, RG/13/6/29947</funders><projectreference/><lastEdited>2025-10-09T16:40:54.2569667</lastEdited><Created>2025-09-25T14:50:05.2470004</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Biomedical Science</level></path><authors><author><firstname>Arne</firstname><surname>Ring</surname><orcid>0000-0002-4324-5820</orcid><order>1</order></author><author><firstname>Tom</firstname><surname>Morris</surname><order>2</order></author><author><firstname>Marcin</firstname><surname>Wozniak</surname><order>3</order></author><author><firstname>Nikol</firstname><surname>Sullo</surname><orcid>0000-0002-9885-5474</orcid><order>4</order></author><author><firstname>William</firstname><surname>Dott</surname><order>5</order></author><author><firstname>Veerle</firstname><surname>Verheyden</surname><order>6</order></author><author><firstname>Tracy</firstname><surname>Kumar</surname><order>7</order></author><author><firstname>Nigel</firstname><surname>Brunskill</surname><order>8</order></author><author><firstname>Rakesh</firstname><surname>Vaja</surname><order>9</order></author><author><firstname>Gavin J.</firstname><surname>Murphy</surname><order>10</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2025-10-09T16:40:54.2569667 v2 70513 2025-09-25 A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study a2c2be54c418e779fd6a010486e1c730 0000-0002-9885-5474 Nikol Sullo Nikol Sullo true false 2025-09-25 MEDS Journal Article British Journal of Clinical Pharmacology 83 4 709 720 Wiley 0306-5251 1365-2125 cardiac surgery; clinical pharmacology; dose proportionality; nitrite oxide; pharmacokinetics; sildenafil 1 4 2017 2017-04-01 10.1111/bcp.13162 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University British Heart Foundation. Grant Numbers: CH/12/1/29419, RG/13/6/29947 2025-10-09T16:40:54.2569667 2025-09-25T14:50:05.2470004 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Biomedical Science Arne Ring 0000-0002-4324-5820 1 Tom Morris 2 Marcin Wozniak 3 Nikol Sullo 0000-0002-9885-5474 4 William Dott 5 Veerle Verheyden 6 Tracy Kumar 7 Nigel Brunskill 8 Rakesh Vaja 9 Gavin J. Murphy 10 |
| title |
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study |
| spellingShingle |
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study Nikol Sullo |
| title_short |
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study |
| title_full |
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study |
| title_fullStr |
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study |
| title_full_unstemmed |
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study |
| title_sort |
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study |
| author_id_str_mv |
a2c2be54c418e779fd6a010486e1c730 |
| author_id_fullname_str_mv |
a2c2be54c418e779fd6a010486e1c730_***_Nikol Sullo |
| author |
Nikol Sullo |
| author2 |
Arne Ring Tom Morris Marcin Wozniak Nikol Sullo William Dott Veerle Verheyden Tracy Kumar Nigel Brunskill Rakesh Vaja Gavin J. Murphy |
| format |
Journal article |
| container_title |
British Journal of Clinical Pharmacology |
| container_volume |
83 |
| container_issue |
4 |
| container_start_page |
709 |
| publishDate |
2017 |
| institution |
Swansea University |
| issn |
0306-5251 1365-2125 |
| doi_str_mv |
10.1111/bcp.13162 |
| publisher |
Wiley |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Biomedical Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Biomedical Science |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2017-04-01T05:31:01Z |
| _version_ |
1851098043666923520 |
| score |
11.444473 |